FASSI, ENRICO MARIO ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 2.923
NA - Nord America 2.251
EU - Europa 2.223
SA - Sud America 291
AF - Africa 82
OC - Oceania 19
Totale 7.789
Nazione #
US - Stati Uniti d'America 2.147
CN - Cina 930
IT - Italia 905
SG - Singapore 716
DE - Germania 349
HK - Hong Kong 301
BR - Brasile 218
VN - Vietnam 210
IN - India 188
RU - Federazione Russa 159
GB - Regno Unito 140
BD - Bangladesh 133
JP - Giappone 122
NL - Olanda 108
FR - Francia 101
KR - Corea 99
SE - Svezia 94
CH - Svizzera 63
CA - Canada 56
FI - Finlandia 56
ID - Indonesia 50
TR - Turchia 46
IE - Irlanda 44
PL - Polonia 37
MX - Messico 35
CI - Costa d'Avorio 33
AT - Austria 31
AR - Argentina 28
ES - Italia 22
IR - Iran 18
PK - Pakistan 18
CL - Cile 16
DK - Danimarca 16
LV - Lettonia 16
BY - Bielorussia 14
ZA - Sudafrica 14
IQ - Iraq 13
AU - Australia 12
BE - Belgio 12
EC - Ecuador 11
TH - Thailandia 9
GR - Grecia 8
MY - Malesia 8
TW - Taiwan 8
UA - Ucraina 8
AE - Emirati Arabi Uniti 7
NZ - Nuova Zelanda 7
PH - Filippine 7
DZ - Algeria 6
EG - Egitto 6
NG - Nigeria 6
RO - Romania 6
VE - Venezuela 6
CO - Colombia 5
JO - Giordania 5
LU - Lussemburgo 5
SI - Slovenia 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
LT - Lituania 4
PE - Perù 4
UZ - Uzbekistan 4
YE - Yemen 4
CR - Costa Rica 3
GE - Georgia 3
MA - Marocco 3
PT - Portogallo 3
RS - Serbia 3
SA - Arabia Saudita 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SC - Seychelles 2
SN - Senegal 2
TN - Tunisia 2
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
EE - Estonia 1
GA - Gabon 1
GM - Gambi 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
PA - Panama 1
Totale 7.782
Città #
Singapore 375
Milan 351
Ashburn 336
Dallas 326
Hong Kong 233
Hanover 174
Hefei 158
San Jose 142
Beijing 122
Los Angeles 112
Chandler 83
Council Bluffs 78
Ho Chi Minh City 71
New York 59
Hanoi 55
Santa Clara 55
Bengaluru 54
Frankfurt am Main 53
Seoul 43
Guangzhou 42
Southend 42
Jakarta 41
Boardman 40
Dublin 40
Lauterbourg 36
Moscow 36
Chicago 34
Shanghai 34
Abidjan 33
Fairfield 32
Houston 31
Buffalo 30
Helsinki 30
Tokyo 30
Munich 29
Rome 29
Lugano 26
Warsaw 23
Woodbridge 22
Istanbul 21
Cangzhou 20
Naples 20
Princeton 20
Piscataway 18
São Paulo 18
Turin 18
Amsterdam 17
Nuremberg 17
Phoenix 17
Wilmington 17
Florence 16
Hangzhou 16
London 16
Riga 16
The Dalles 16
Central 15
Changsha 15
Chengdu 15
Düsseldorf 15
Berlin 14
Brooklyn 14
Cambridge 14
Cheongju-si 14
Columbus 14
Mexico City 14
Minsk 14
Montreal 14
Lappeenranta 13
Seattle 13
Shenzhen 13
Atlanta 12
Burnaby 12
Turku 12
Wuhan 12
Mumbai 11
Orem 11
Poplar 11
Tesserete 11
Tradate 11
Varedo 11
Vienna 11
Cagliari 10
Dong Ket 10
Gongju 10
Redwood City 10
Rho 10
Rio de Janeiro 10
Cary 9
Da Nang 9
Denver 9
Fuzhou 9
Santiago 9
Ankara 8
Boston 8
Buenos Aires 8
Hyderabad 8
Modena 8
Monza 8
Nanjing 8
San Diego 8
Totale 4.328
Nome #
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction 515
PCSK9 inhibitors: a patent review 2018-2023 384
Elucidating the 3D Structure of a Surface Membrane Antigen from Trypanosoma cruzi as a Serodiagnostic Biomarker of Chagas Disease 327
Exploring Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Autoproteolysis Process by Molecular Simulations: Hints for Drug Design 319
Structure, Immunoreactivity, and In Silico Epitope Determination of {SmSPI} S. mansoni Serpin for Immunodiagnostic Application 277
Analysis of Hsp90 allosteric modulators interactome reveals a potential dual action mode involving mitochondrial MDH2 269
Elagolix analogues as potential new GnRH antagonists: design, synthesis and characterization 262
Natural compounds targeting E. Coli WRBA as antibiofilm agents: Virtual screening, design and synthesis of analogs, biological evaluation 248
Investigation of Chlorella pyrenoidosa Protein as a Source of Novel Angiotensin I-Converting Enzyme (ACE) and Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides 227
Oxidation State Dependent Conformational Changes of HMGB1 Regulate the Formation of the CXCL12/HMGB1 Heterocomplex 225
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS 219
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists 209
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study 208
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment 205
Trans-Epithelial Transport, Metabolism and Biological Activity Assessment of the Multi-Target Lupin Peptide LILPKHSDAD (P5) and Its Metabolite LPKHSDAD (P5-Met) 204
Computational Design, Synthesis, and Biological Evaluation of Diimidazole Analogues Endowed with Dual PCSK9/HMG-CoAR-Inhibiting Activity 201
Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity 195
Natural and nature-inspired compounds targeting E. coli WrbA as antibiofilm agents: computational studies, synthesis, and biological evaluation 190
Insights on the atropisomeric properties of elagolix and its derivatives 189
Elagolix analogues as potential new GnRH antagonists 186
COMPUTATIONAL DESIGN OF PEPTIDES AND PEPTIDOMIMETICS AS POTENTIAL THERAPEUTIC AGENTS TO SATISFY PRESSING MEDICAL NEEDS 185
Unlocking the Antibiofilm Potential of Natural Compounds by Targeting the NADH:quinone Oxidoreductase WrbA 184
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists 183
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid 172
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 172
Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors 164
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer 160
A new class of GnRH receptor modulators endowed with atropisomerism 157
A potent nonapeptide inhibitor for the CXCL12/HMGB1 heterocomplex: A computational and experimental approach 151
High‐throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development 151
Modulatori Fotosensibili dell’adesione batterica: una nuova strategia per ridurre l’antibiotico-resistenza 150
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines 147
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation 144
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS. 139
Light-Responsive Modulators of Bacterial Cell Adhesion Proteins: a Novel Strategy against AMR? 137
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity 125
Insights on Zosteric Acid Analogues Activity Against Candida albicans Biofilm Formation 116
Development of AMBER Parameters for Molecular Simulations of Selected Boron-Based Covalent Ligands 103
Spatiotemporal Control of Bacterial Adhesion via Light-Responsive Modulators 66
Design and synthesis of CD70 inhibitors: a potential way for the treatment of ulcerative colitis 42
Insights into the catalytic mechanism of formate dehydrogenases from different microbial sources 36
Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics 33
Endoplasmic Reticulum and Lysosomal Quality Control of Four Nonsense Mutants of Iduronate 2-Sulfatase Linked to Hunter{'}s Syndrome 19
Computational Analysis of Dengue Virus Envelope Protein (E) Reveals an Epitope with Flavivirus Immunodiagnostic Potential in Peptide Microarrays 16
null 9
PCSK9 inhibitors: an updated patent review 2024–2025 6
Totale 8.026
Categoria #
all - tutte 23.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022557 18 25 16 16 40 25 33 43 119 92 74 56
2022/2023483 43 55 37 33 25 50 5 63 48 23 50 51
2023/2024851 42 32 59 74 123 62 135 43 44 57 94 86
2024/20251.582 67 121 43 132 101 91 97 160 77 147 238 308
2025/20264.310 384 393 583 488 364 205 540 172 379 316 400 86
Totale 8.026